HB383 - To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
US Congress - 118th Congress
Introduced byDiana Harshbarger, Kevin Hern, Doug Lamborn
Last updated over 1 year ago
27 Co-Sponsors
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now